Crossmark

High-Throughput Screening Assay Identifies Berberine and Mubritinib as Neuroprotection Drugs for Spinal Cord Injury via Blood-Spinal Cord Barrier Protection

Crossref DOI link: https://doi.org/10.1007/s13311-022-01310-y

Published Print: 2022-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Suzuki, Yuki

Nakagawa, Shinsuke

Endo, Takeshi

Sotome, Akihito

Yuan, Rufei

Asano, Tsuyoshi

Otsuguro, Satoko

Maenaka, Katsumi

Iwasaki, Norimasa

Kadoya, Ken https://orcid.org/0000-0001-5432-3866
License Information

Text and Data Mining valid from 2022-10-01

Text and Data Mining valid from 2022-10-01

Version of Record valid from 2023-08-07
More Information

This article is maintained by: Elsevier

Article Title: High-Throughput Screening Assay Identifies Berberine and Mubritinib as Neuroprotection Drugs for Spinal Cord Injury via Blood-Spinal Cord Barrier Protection

Journal Title: Neurotherapeutics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-022-01310-y

Content Type: article

Copyright: Copyright © 2022 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.

Document is current

Any future updates will be listed below